Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

R Pofi, G Caratti, DW Ray, JW Tomlinson - Endocrine Reviews, 2023 - academic.oup.com
It is estimated that 2% to 3% of the population are currently prescribed systemic or topical
glucocorticoid treatment. The potent anti-inflammatory action of glucocorticoids to deliver …

Prevention and treatment of glucocorticoid-induced osteoporosis in adults: consensus recommendations from the Belgian bone club

MR Laurent, S Goemaere, C Verroken… - Frontiers in …, 2022 - frontiersin.org
Glucocorticoids are effective immunomodulatory drugs used for many inflammatory
disorders as well as in transplant recipients. However, both iatrogenic and endogenous …

Glucocorticoid-induced osteoporosis: 2019 concise clinical review

G Adami, KG Saag - Osteoporosis International, 2019 - Springer
Glucocorticoids remain widely used for many medical conditions, and fractures are the most
serious common adverse event related to long-term glucocorticoid use. Glucocorticoid …

Osteoporosis pathophysiology, epidemiology, and screening in rheumatoid arthritis

G Adami, KG Saag - Current rheumatology reports, 2019 - Springer
Abstract Purpose of Review To review the burden of osteoporosis (OP) in rheumatoid
arthritis (RA) and to describe the OP screening strategies applied in RA. Recent Findings RA …

Glucocorticoid-induced osteoporosis update

G Adami, KG Saag - Current Opinion in Rheumatology, 2019 - journals.lww.com
Glucocorticoid-induced osteoporosis update : Current Opinion in Rheumatology
Glucocorticoid-induced osteoporosis update : Current Opinion in Rheumatology Log in or …

Risk for osteoporosis and fracture with glucocorticoids

M Urquiaga, KG Saag - Best Practice & Research Clinical Rheumatology, 2022 - Elsevier
Glucocorticoid use is ubiquitous and is associated with multiple adverse reactions. Among
them, osteoporosis and bone fractures are of our concern. In this review, we present current …

Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low‐Dose Glucocorticoids and Prevention by Anti‐Osteoporosis Medications

G Adami, A Fassio, M Rossini, C Benini… - Arthritis & …, 2023 - Wiley Online Library
Objective The negative effects of glucocorticoids on bone depend on dose and treatment
duration. However, it is unclear whether a safe dose exists, especially for patients with …

Management of glucocorticoid-induced osteoporosis

OD Messina, LF Vidal, MV Wilman, IEM Bultink… - Aging Clinical and …, 2021 - Springer
Long-term glucocorticoid (GC) therapy is frequently indicated to treat autoimmune and
chronic inflammatory diseases in daily clinical practice. Two of the most devastating …

Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based …

S Abtahi, JHM Driessen, AM Burden… - Annals of the …, 2021 - ard.bmj.com
Background Patients with rheumatoid arthritis (RA) commonly use oral glucocorticoids (GCs)
and proton pump inhibitors (PPIs), both associated with osteoporotic fractures. We …

Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis

C Iacopo, F Alberto, M Daniela… - Expert Review of …, 2020 - Taylor & Francis
Introduction Endogenous or exogenous (corticosteroid-induced) glucocorticoids (GCs)
excess represents, together with diabetes, the most common cause of secondary …